Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Synlogic
Biotech
Layoffs, end of line for Synlogic after PKU drug's phase 3 fail
Synlogic’s dreams have gone up in smoke on news that a phase 3 study of its lead phenylketonuria drug is on track to miss its primary endpoint.
James Waldron
Feb 9, 2024 7:11am
Science 37 tapped for Synlogic's phase 3 trial of PKU treatment
Jul 12, 2023 3:25pm
SQZ, Synlogic pulled into biotech’s layoff sinkhole
Dec 1, 2022 11:34am
What does a virtual J.P. Morgan mean for the meeting's future?
Jan 12, 2021 11:00am
JPM: 4 women biopharma vets discuss their first biotech CEO role
Jan 15, 2020 7:25am
Synlogic CEO Brennan on lessons learned and what's up in 2020
Jan 14, 2020 9:10am